Whilst the government alluded to a likely fourth dose in the coming months, Head of Haute Autorité de Santé vaccinal technique commission Elisabeth Bouvet said it was currently “not sure at all we would need a fourth dose”, on France Info.
Covid-19 Omicron variant could enable to reach a genuine herd immunity, and natural thanks to the quick spread. Furthermore, an extra dose of vaccine does not seem “justified” for the time being, according to Elisabeth Bouvet. For the Haute Autorité de Santé, the vaccinal scheme is based on two doses and a booster for the general population. They add for people at risk or immunocompromised, a fourth dose could be useful to boost their immunity. But, for the rest, data are not ruling for an extra dose.
About herd immunity, the organization considers we have “one already”. Waves by waves, the impact on hospitalizations in ICU decreases. Although it is necessary to stay cautious with a disease, we lack information about, variants tend to weaken over time, leading to less considerable damage on the population that grew well-immunized.
About 52 million people enjoy a complete vaccinal scheme, which is 79% of the French population. The head of the vaccinal technique commission hopes with the approval of the Novavax vaccine, people not willing to get vaccinated will eventually take the leap as the latter is more standard than the others currently available.
